Speaker Profile
M.D., Ph.D., Chief Scientific Officer & Vice President, BioAro
Biography
Precision health OMICs Innovation translational clinical research specialist with extensive experience in Operational leadership to large Provincial University programs SMEs for:1.Creation of an inclusive Ecosystem of Clinical Research Innovation Entrepreneurship2.Translation commercialization of innovative research into clinicmarket3.Strategic initiatives to develop Cutting-edge infrastructure HQP training programs 4.Integration of AIML Quantum tools and Big data into practise 5.Indigenousunderrepresented community outreach for research engagement. Raja is the Chief Scientific Officer, BioAro Inc, (and Vice President, Research Innovation, CardiAI Inc.). Earlier he was with the Faculty of Medicine Dentistry University of Alberta, as Director, Alberta Prostate Cancer Network (APCaRI), Director, Alberta Health Network (AAHN) and as Director, Genome Alberta (Alberta Epigenetics Network), Alberta Canada. Trained as a Physician, Raja obtained his PhD in Cardiovascular Sciences. He has published extensively in high impact peer-reviewed medical journals and written book chapters in cardiac research, genomics, epigenomics and microbiome investigations.
Talk
Unveiling Power of AI with PanOmiQ Analysis
AI and ML powered end to end genomic analysis is critical for providing precision medicine based support to our patients. PanOmiQ is the first software platform to do so.
Genomic Profiling Showcase:
BioAro
BioAro Inc. is a Calgary based Canadian company providing personalized medicine services to patients through development of AI based software platforms for analyiss and integration of multi-OMICS data into clinical care
Session Abstract – PMWC 2025 Silicon Valley
The PMWC 2025 Genomic Profiling Showcase will provide a 15-30 min speaking opportunity for selected companies working with the latest technologies in nucleic acid sequencing such as NGS, providing instrumentation for genomic sequencing, and offering direct to consumer services. These companies will share their innovative products and services to an audience of leading investors, potential clients and partners. The Genomic Profiling Showcase will exhibit the latest innovations in methods and instruments used for DNA/ RNA sequencing to ascertain the genomic and transcriptional profile of a person in order to understand why some people get certain diseases while others do not, or why people react in different ways to the same drug. This information is also being used to develop new ways to diagnose, treat, and prevent diseases, such as cancer.
